Mirae Asset Global Investments
TYRA icon

Mirae Asset Global Investments’s Tyra Biosciences TYRA Stock Holding History

Mirae Asset Global Investments’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85K Sell
2,660
-124
-4% -$4.1K ﹤0.01% 1271
2026
Q1 		$107K Buy
2,784
+190
+7% +$6.15K ﹤0.01% 1167
2025
Q4 		$68.2K Buy
2,594
+534
+26% +$9.81K ﹤0.01% 1338
2025
Q3 		$28.8K Buy
2,060
+6
+0.3% +$68 ﹤0.01% 1443
2025
Q2 		$19.7K Buy
2,054
+361
+21% +$3.43K ﹤0.01% 1401
2025
Q1 		$16.5K Buy
1,693
+7
+0.4% +$91 ﹤0.01% 1404
2024
Q4 		$23.7K Buy
+1,686
New +$30.6K ﹤0.01% 1395

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Mirae Asset Global Investments's TYRA Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Tyra Biosciences (TYRA) stake by 4.5% in Q2 2026, selling an estimated $4.1K and leaving 2,660 shares worth $85K. The position accounts for ﹤0.01% of the portfolio, ranked #1271.

Mirae Asset Global Investments first reported a position in TYRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $107K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Mirae Asset Global Investments held 2,660 shares of Tyra Biosciences worth $85K as of Q2 2026.
  • Mirae Asset Global Investments sold 124 Tyra Biosciences shares in Q2 2026, an estimated $4.1K.
  • Tyra Biosciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1271 holding.
  • Mirae Asset Global Investments first reported a position in Tyra Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Tyra Biosciences position peaked at $107K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.